SNBP News and Press, Sun BioPharma Inc From 05/14/19

Sun BioPharma ( OTCQB:SNBP ): Q1 GAAP EPS of -$0.31. More news on: Sun BioPharma, Inc., Earnings news and commentary, Tech stocks news, , Read more ...

Enrollment in Second Cohort of PDA Combination Study Completed New Funding Totaling $0.8 Million Secured MINNEAPOLIS, May 14, 2019 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment ...

Sun BioPharma ( OTCQB:SNBP ): Q4 GAAP EPS of -$0.16. Cash of $1.41M Press Release More news on: Sun BioPharma, Inc., Earnings news and commentary, Tech stocks news, ,

Front-Line Combination Study with Gemcitabine and Nab-Paclitaxel enrolling second Cohort of Phase 1a Company reinstates founder and Executive Chairman, Dr. Michael Cullen as President and Chief Executive Officer, effective November 1, 2018 $2.2M in private financing raised between ...